Hepatitis b drug trial halted after early safety check

NCT ID NCT05763576

Terminated Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new medicine called RO7565020 in healthy volunteers and people with chronic hepatitis B. The goal was to see if the drug is safe and how the body processes it. The trial was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEPATITIS B

Contacts and locations

Locations

Chang Gung Medical Foundation Linkou Branch

Taoyuan City, 333, Taiwan
Faculty of Medicine Siriraj Hospital

Bangkok, 10700, Thailand
Hallym University Chuncheon Sacred Heart Hospital

Chuncheon, 24253, South Korea
Hospital Alvaro Cunqueiro

Vigo, Pontevedra, 36312, Spain
Maharaj Nakorn Chiang Mai Hospital

Chiang Mai, 50200, Thailand
New Zealand Clinical Research - Auckland

Auckland, 1010, New Zealand
Prince of Wales Hospital

Shatin, New Territories, Hong Kong
Queen Mary Hospital

Hong Kong, Hong Kong
Quest Clinical Research

San Francisco, California, 94115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.